Childhood obesity: a growing pandemic

doi : 10.1016/S2213-8587(21)00314-4

Volume 10, Issue 1

Buy The Package and View The Article Online

SGLT-2 inhibitors: does it matter if they prevent type 2 diabetes

Alice Y YChenga

doi : 10.1016/S2213-8587(21)00310-7

Buy The Package and View The Article Online

Is the impact of add on heart failure therapy influenced by background therapy?

LarsRydénaGiuliaFerranninia

doi : 10.1016/S2213-8587(21)00311-9

Buy The Package and View The Article Online

The changing character of diabetes complications

SrikanthBellarya

doi : 10.1016/S2213-8587(21)00313-2

Buy The Package and View The Article Online

Opportunities and challenges in closed-loop systems in type 1 diabetes

Leah MWilsonaPeter GJacobsbMichael CRiddellcDessi PZaharievadJessica RCastlea

doi : 10.1016/S2213-8587(21)00289-8

Buy The Package and View The Article Online

Telehealth for people with diabetes: poised for a new approach

Korey KHoodaJessie JWonga

doi : 10.1016/S2213-8587(21)00312-0

Buy The Package and View The Article Online

Youth-onset type 2 diabetes among First Nations young people in northern Australia: a retrospective, cross-sectional study

AngelaTitmussabdElizabeth ADaviseVickiO'DonnellfMarkWenitonggLouise JMaple-Brownac†AveniHaynese†

doi : 10.1016/S2213-8587(21)00286-2

Buy The Package and View The Article Online

COVID-19 targets human adrenal glands

WaldemarKanczkowskiaKatjaEverteMarlenaStadtmüllerbMartinaHabereckerfLauraLakshLan-SunChenbKarlFrontzekhJessicaPablikcConstanzeHantelaghFelixBeuschleinghThomasKurthdSvenGruberghAdrianoAguzzihZsuzsannaVargafStefan RBornsteinai

doi : 10.1016/S2213-8587(21)00291-6

Buy The Package and View The Article Online

Access to insulin and diabetes care in the Philippines

Michelle Ann BEalaaJohn Jefferson VBesabRegiel Christian QMag-usarabAnna Elvira SArcellanacCecilia AJimenocd

doi : 10.1016/S2213-8587(21)00309-0

Buy The Package and View The Article Online

Diabetes and the WHO Model List of Essential Medicines

Farah NKhanaIrl BHirscha

doi : 10.1016/S2213-8587(21)00318-1

Buy The Package and View The Article Online

Diabetes and the WHO Model List of Essential Medicines

DavidBeranaStéphaneBesançonbMargaretEwencEdwin A MGaledMariaLazo-PorrasefMollyLepeskacKasiaLipskagJessicaZafra-TanakaefAigerimZhaparovahJohn SYudkini

doi : 10.1016/S2213-8587(21)00323-5

Buy The Package and View The Article Online

Diabetes and the WHO Model List of Essential Medicines

DanneabFrancisco JavierAmpudia-BlascocdChantalMathieuef

doi : 10.1016/S2213-8587(21)00322-3

Buy The Package and View The Article Online

Diabetes and the WHO Model List of Essential Medicines

RanjitUnnikrishnanabViswanathanMohanab

doi : 10.1016/S2213-8587(21)00321-1

Buy The Package and View The Article Online

Diabetes and the WHO Model List of Essential Medicines

AmulyaReddya

doi : 10.1016/S2213-8587(21)00320-X

Buy The Package and View The Article Online

Diabetes and the WHO Model List of Essential Medicines

Carissa FEtiennea

doi : 10.1016/S2213-8587(21)00317-X

Buy The Package and View The Article Online

Viswanathan Mohan: a dynasty of diabetology

CarlPower

doi : 10.1016/S2213-8587(21)00316-8

Buy The Package and View The Article Online

COVID-19 and diabetes in Africa: a lethal combination

TalhaBurki

doi : 10.1016/S2213-8587(21)00315-6

Buy The Package and View The Article Online

Correction to Lancet Diabetes Endocrinol 2022; 10: 58–74

doi : 10.1016/S2213-8587(21)00324-7

Buy The Package and View The Article Online

Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials

ProfPeterRossingMDabProfSilvio EInzucchicPriyaVartPhDdNielsJongsPhDdKieran FDochertyMBChBePardeep SJhundMBChBeProfLarsKøberMDfProfMikhail NKosiborodMDghProfFelipe AMartinezMDiProfPiotrPonikowskiMDjMarc SSabatineMDklScott DSolomonMDklProfDavid LDeMetsPhDmOlofBengtssonPhLicnMagnusLindbergMScnAnna MariaLangkildeMDnMikaelaSjöstrandMDnBergur VStefanssonMDn…ProfHiddo J LHeerspinkPhDdt

doi : 10.1016/S2213-8587(21)00295-3

Buy The Package and View The Article Online

Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

ProfSubodhVermaMDaNitish KDhingraBHScaProfJavedButlerMDbProfStefan DAnkerMDcJoao PedroFerreiraMDdeGerasimosFilippatosMDfJames LJanuzziMDgProfCarolyn S PLamMDhProfNaveedSattarMDiBarbaraPeilDrSc humjMatiasNordabyMDkMartinaBrueckmannMDklProfStuart JPocockPhDmProfFaiezZannadMDdProfMiltonPackerMDno

doi : 10.1016/S2213-8587(21)00292-8

Buy The Package and View The Article Online

Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records

JonathanPearson-StuttardFRSPHabYiling JChengPhDgJamesBennettPhDabEszter PVamosFFPHcBinZhouPhDabfProfJonathanValabhjiMDdhiProfAmanda JCrossPhDaeProfMajidEzzatiFMedSciabfjProfEdward WGreggPhDab

doi : 10.1016/S2213-8587(21)00288-6

Buy The Package and View The Article Online

Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals

KatarinaBrauneMDabc*Rayhan ALalMDd*LenkaPetruželkováMDeGaryScheinerCDCESfPerWinterdijkMDgSigneSchmidtMDhLindaRaimondDSNhProfKorey KHoodPhDdProfMichael CRiddellPhDiProfTimothy CSkinnerPhDjkProfKlemensRaileMDaSufyanHussainPhDlmnOPEN International Healthcare Professional Network and OPEN Legal Advisory Group†

doi : 10.1016/S2213-8587(21)00267-9

Buy The Package and View The Article Online

Glycaemic management in diabetes: old and new approaches

ProfAntonioCerielloMDaFrancescoPrattichizzoPhDaProfMoshePhillipMDbcProfIrl BHirschMDdProfChantalMathieuMDeProfTadejBattelinoMDfg

doi : 10.1016/S2213-8587(21)00245-X

Buy The Package and View The Article Online